Tag: #SurvivalRates
-
Elderly Multiple Myeloma Patients Benefit Equally from Stem Cell Transplantation: A New Perspective
Introduction Multiple Myeloma (MM) is a plasma cell malignancy affecting millions worldwide. While autologous hematopoietic stem cell transplantation (AHSCT) is a standard treatment for eligible patients, concerns remain regarding its effectiveness in elderly individuals. However, new research suggests that patients over 70 years of age benefit equally from AHSCT compared to younger counterparts. Visit https://www.stemcelltherjournal.com/jsctt…
Heighten Science Publications Inc. 